Stem Cells in Regenerative Medicine
Science, Regulation and Business Strategies
Stem cells, as therapeutic agents or as research or diagnostics tools, represent an emerging technology with a transformational potential that parallels the paradigm shift operated by the development of monoclonal antibodies in the 1990s, or even the coming of age of genetic engineering technology platforms in the 1980s. Those working with stem cell technologies face a complex matrix of ethical, regulatory, policy, logistics, supply chain, manufacturing, pricing and reimbursement challenges. This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the sc…
Mehr
CHF 137.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Qureshi, Nasib (Hrsg.) / Babiss, Lee E. (Hrsg.) / Caplan, Arnold I. (Hrsg.)
- ISBN: 978-1-118-84620-9
- EAN: 9781118846209
- Produktnummer: 18933239
- Verlag: Wiley-Blackwell
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 776 S.
- Plattform: PDF
- Masse: 16'067 KB
Über den Autor
Alain A. Vertès, London Business School, London, UK Nasib Qureshi, United States Department of Agriculture (ARS), National Center for Agricultural Utilization Research, Illinois, USA Arnold I. Caplan, Case Western Reserve University, Ohio, USA Lee Babiss, Pharmaceutical Product Development, North Carolina, USA
7 weitere Werke von Alain A. (Hrsg.) Vertes:
Bewertungen
Anmelden